No association between vascular inflammation and estimated glomerular filtration rate in patients with rheumatoid arthritis: secondary analysis of the TARGET trial.
作者信息
Fukui S, Tawakol A, Winkelmayer W C, Santacroce L M, Giles J T, Liao K P, Bathon J M, Solomon D H
机构信息
Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
出版信息
Scand J Rheumatol. 2025 May;54(3):213-216. doi: 10.1080/03009742.2025.2455878. Epub 2025 Feb 5.
Abstract
摘要
相似文献
1
No association between vascular inflammation and estimated glomerular filtration rate in patients with rheumatoid arthritis: secondary analysis of the TARGET trial.类风湿关节炎患者血管炎症与估计肾小球滤过率之间无关联：TARGET试验的二次分析
Scand J Rheumatol. 2025 May;54(3):213-216. doi: 10.1080/03009742.2025.2455878. Epub 2025 Feb 5.
2
Association of metabolic syndrome with urinary albumin excretion, low-grade inflammation, and low glomerular filtration rate among non-diabetic Japanese subjects.非糖尿病日本受试者中代谢综合征与尿白蛋白排泄、低度炎症及低肾小球滤过率的关联
Intern Med. 2009;48(21):1855-62. doi: 10.2169/internalmedicine.48.2471. Epub 2009 Nov 2.
3
Outcomes of living kidney donors with rheumatoid arthritis.患有类风湿性关节炎的活体肾供者的结局
Prog Transplant. 2015 Dec;25(4):307-10. doi: 10.7182/pit2015229.
4
Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study.应用肌酐和胱抑素 C 估算肾小球滤过率识别和监测中度慢性肾脏病的准确性：eGFR-C 研究。
Health Technol Assess. 2024 Jul;28(35):1-169. doi: 10.3310/HYHN1078.
5
Utility of estimated glomerular filtration rate using cystatin C and its interpretation in patients with rheumatoid arthritis under glucocorticoid therapy.胱抑素 C 估算肾小球滤过率的临床应用及其在接受糖皮质激素治疗的类风湿关节炎患者中的解读。
Clin Chim Acta. 2018 Dec;487:299-305. doi: 10.1016/j.cca.2018.10.022. Epub 2018 Oct 12.
6
Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial.托法替布对活动性类风湿关节炎患者测量的肾小球滤过率的影响评估：一项随机对照试验的结果
Arthritis Res Ther. 2015 Apr 6;17(1):95. doi: 10.1186/s13075-015-0612-7.
7
Risk Factors Associated with Estimated Glomerular Filtration Rate in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis after Treatment with Biological Disease Modifying Anti-Rheumatic Drugs.类风湿关节炎和强直性脊柱炎患者接受生物改善病情抗风湿药物治疗后，与估算肾小球滤过率相关的危险因素
J Korean Med Sci. 2018 Jun 26;33(30):e214. doi: 10.3346/jkms.2018.33.e214. eCollection 2018 Jul 23.
8
Estimated glomerular filtration rate in observational and interventional studies in chronic kidney disease.在慢性肾脏病的观察性和干预性研究中估算肾小球滤过率。
J Nephrol. 2024 Apr;37(3):573-586. doi: 10.1007/s40620-024-01887-x. Epub 2024 Feb 12.
9
The Association of Disease Activity and Estimated GFR in Patients With Rheumatoid Arthritis: Findings From the ANSWER Study.类风湿关节炎患者疾病活动度与估算肾小球滤过率的相关性：ANSWER研究结果
Am J Kidney Dis. 2021 Nov;78(5):761-764. doi: 10.1053/j.ajkd.2021.02.338. Epub 2021 May 10.
10
Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease.生物制剂治疗类风湿关节炎可降低新发慢性肾脏病的风险。
Kidney Int. 2018 May;93(5):1207-1216. doi: 10.1016/j.kint.2017.11.025. Epub 2018 Mar 2.
本文引用的文献
1
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study.类风湿关节炎的疾病活动与肾功能下降：一项大型前瞻性注册研究。
Ann Rheum Dis. 2025 Feb;84(2):201-209. doi: 10.1136/ard-2024-226156. Epub 2025 Jan 2.
2
Immune and inflammatory mechanisms in hypertension.高血压中的免疫和炎症机制。
Nat Rev Cardiol. 2024 Jun;21(6):396-416. doi: 10.1038/s41569-023-00964-1. Epub 2024 Jan 3.
3
Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis.用免疫调节剂降低心血管风险：类风湿关节炎患者中的一项随机活性对照试验。
Ann Rheum Dis. 2023 Mar;82(3):324-330. doi: 10.1136/ard-2022-223302. Epub 2022 Nov 30.
4
Use of biologic agents and methotrexate improves renal manifestation and outcome in patients with rheumatoid arthritis: a retrospective analysis.生物制剂和甲氨蝶呤的使用改善了类风湿关节炎患者的肾脏表现和结局：一项回顾性分析。
Clin Exp Nephrol. 2022 Apr;26(4):341-349. doi: 10.1007/s10157-021-02160-2. Epub 2021 Nov 30.
5
Effect of Low-Dose Methotrexate on eGFR and Kidney Adverse Events: A Randomized Clinical Trial.低剂量甲氨蝶呤对 eGFR 和肾脏不良事件的影响：一项随机临床试验。
J Am Soc Nephrol. 2021 Dec 1;32(12):3197-3207. doi: 10.1681/ASN.2021050598.
6
Renal Manifestations of Rheumatoid Arthritis.类风湿关节炎的肾脏表现
Rheum Dis Clin North Am. 2018 Nov;44(4):571-584. doi: 10.1016/j.rdc.2018.06.008. Epub 2018 Sep 7.
7
Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease.生物制剂治疗类风湿关节炎可降低新发慢性肾脏病的风险。
Kidney Int. 2018 May;93(5):1207-1216. doi: 10.1016/j.kint.2017.11.025. Epub 2018 Mar 2.
Zotero 插件